These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
682 related items for PubMed ID: 24880653
1. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study. Weiss A, Neril R, Geslevich J, Lavee M, Beck-Fruchter R, Golan J, Shalev E. Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653 [Abstract] [Full Text] [Related]
2. Prolonging oocyte in vitro culture and handling time does not compensate for a shorter interval from human chorionic gonadotropin administration to oocyte pickup. Garor R, Shufaro Y, Kotler N, Shefer D, Krasilnikov N, Ben-Haroush A, Pinkas H, Fisch B, Sapir O. Fertil Steril; 2015 Jan; 103(1):72-5. PubMed ID: 25439844 [Abstract] [Full Text] [Related]
4. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Lu X, Hong Q, Sun L, Chen Q, Fu Y, Ai A, Lyu Q, Kuang Y. Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046 [Abstract] [Full Text] [Related]
6. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Zilberberg E, Haas J, Dar S, Kedem A, Machtinger R, Orvieto R. Gynecol Endocrinol; 2015 Feb; 31(2):145-7. PubMed ID: 25385007 [Abstract] [Full Text] [Related]
7. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403 [Abstract] [Full Text] [Related]
9. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM. Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928 [Abstract] [Full Text] [Related]
10. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval. Raziel A, Schachter M, Strassburger D, Kasterstein E, Ron-El R, Friedler S. Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475 [Abstract] [Full Text] [Related]
12. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study. Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P. Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330 [Abstract] [Full Text] [Related]
13. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg. Zhu X, Ye H, Fu Y. Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446 [Abstract] [Full Text] [Related]
14. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation? Kedem A, Tsur A, Haas J, Yerushalmi GM, Hourvitz A, Machtinger R, Orvieto R. Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364 [Abstract] [Full Text] [Related]
15. How many eggs are needed to produce an assisted reproductive technology baby: is more always better? McAvey B, Zapantis A, Jindal SK, Lieman HJ, Polotsky AJ. Fertil Steril; 2011 Aug; 96(2):332-5. PubMed ID: 21718991 [Abstract] [Full Text] [Related]
16. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study. Lin H, Wang W, Li Y, Chen X, Yang D, Zhang Q. Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):143-7. PubMed ID: 21824709 [Abstract] [Full Text] [Related]